Replies to post #579835 on NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

I believe this John Hopkins Professor encapsulates your sentiment to the letter: https://rumble.com/v2bic2u-dr.-marty-makary-the-greatest-perpetrator-of-misinformation-during-covid-wa.html

Martin Adel Makary is a British-American surgeon, professor, author and medical commentator. He practices surgical oncology and gastrointestinal laparoscopic surgery at the Johns Hopkins Hospital, is Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins School of Medicine, and teaches public health policy as Professor of Surgery and Public Health at the Johns Hopkins Bloomberg School of Public Health.

ILT

[Dan88]

For most pre-commercial biotech companies seeking FDA approval, manufacturing readiness is usually the last step to check by FDA before its making decision on whether to approve the underlining drug/biological product/vaccine, so in this sense June 2023 is more than achievable since UK MHRA has just checked the readiness item (module).

By the time when MAA is submitted, it's also possible MHRA has reviewed most, if not all contents of MAA, so it is certainly possible the approval may come earlier than a lot of folks would expect.

Regardless, it becomes easier by the days/months to hold and/or add more shares as we have done just that already for years, if not a decade.

[exwannabe]

Haha! Oh boy. Well Ex, let’s make a bet. I’m thinking MAA approval in June 2023.

Game on.

[exwannabe]

Haha! Oh boy. Well Ex, let’s make a bet. I’m thinking MAA approval in June 2023. I know I’ve been wrong on a lot of timeline predictions, but when in life new information comes to light most intelligent people reserve the right to change their minds and create new views based upon that new information

Dr Zivoc, you asserted in fall 2022 that approval would be by end of that year.

Then you rebooted with this bet for June 2023.

Want to try again for June 2024?